Transforming emergency care through faster, more efficient cardiopulmonary diagnostics
We are tackling the global emergency care bottleneck with breakthrough, contactless AI cardiopulmonary diagnostics, orienting patients inunder two minutes.
i-Nov 2025 awardee
Backed by the France 2030 plan, the i-Nov Innovation Competition empowers highly innovative projects driving the future of the French economy.
.png){kind=logo}
.svg){kind=logo}
The challenge we’re tackling
Every year, millions of patients worldwide present to emergency departments (ED) with cardiopulmonary symptoms, placing high pressure on hospitals and healthcare professionals with limited time and resources. AUSTRAL Dx aims at tackling this challenge with faster, more efficient diagnostic solutions, enabling more streamlined patient pathways.
500M
Nearly 500 M annual ED visits across the EU, US and China
80M
15 to 20% of patients suffering from chest pain and/or dyspnea (difficulty breathing)
3 hours
On average, to identify the root cause behind the symptoms
Our technology
The technology "ADx-One" that we are developing shall represent a paradigm shift in emergency diagnostics. Unlike traditional pathways that require multiple separate examinations and specialist interpretation, our technology can simultaneously capture comprehensive heart and lung data in a single, brief, contactless scan without requiring a trained resource for data acquisition. The proprietary Surface Motion Camera technology uses airborne ultrasound to detect minute thoracic vibrations invisible to the human eye, creating a rich dataset that our embedded AI analyzes in real-time to identify pathological signatures.
Heart and lungs exam at once
Like 1,000 parallel stethoscopes listening up to 1,000× per second, capturing comprehensive cardiopulmonary data simultaneously
Non-invasive, airborne ultrasound technique
Contactless auscultation completed in less than 2 minutes with no patient discomfort
Successful
First-in-Human Proof of Concept
Conducted in 2025 in 213 patients in CHU Caen-Normandie
Fully automated and AI-powered medical device
Thanks to automated data monitoring, transfer, and intelligent analysis, our technology can be managed by non-medical experts which can contribute to faster diagnosis by healthcare practitioners.
Easy-to-use with immediate results
Operator-independent with transferable data and real-time diagnostic insights
Want to help us transform emergency care?
Learn more about AUSTRAL Dx, our vision, and the technology behind our airborne ultrasound device.
Key facts and figures
Established in 2021
| 5+ years of expertise
| Targeting commercialization
by 2028
213 participants in our proof of concept clinical study
A dedicated team
of 11 experts
The number
of patents
For hospitals’ staff and healthcare practitioners
A reliable and precise technology to improve clinical pathways. Physicians can focus on what they do best : clinical decision-making and patient care.
For patients
Improving their journey with fast and reliable diagnosis.
Faster diagnosis means faster treatment and better outcomes.
For hospitals
Per-patient budget and resource optimization.
The diagnostic time reduction shall directly generate economic savings for hospitals and increase throughput capacity.
For healthcare professionals
Optimizing organization through better assessment of patient influx.
AUSTRAL Dx is built on a strong ecosystem of scientific, clinical, and institutional partners
We are building a strong network of trusted partners who support our development, reinforcing our credibility and leadership: from renowned hospitals and research centers to health incubators and public funders.
What’s New
Explore our latest updates
Proud to be backed by
Want to help us transform emergency care?
Learn more about AUSTRAL Dx, our vision, and the technology behind our airborne ultrasound medical device.